This compound is a benzenesulfonamide derivative supplied as an active pharmaceutical ingredient. It is a hydrochloride salt with a complex aromatic and heterocyclic structure, characterized by multiple ether and alcohol functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1196074-08-4
Bosentan
pharmaceutical raw material
Bosentan hydrate
pharmaceutical raw material
4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
pharmaceutical intermediate
Olprinone hydrochloride
pharmaceutical raw material
2-[2-[1-(4-chloro-2,3,5,6-tetradeuteriobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid
pharmaceutical raw material
Diclofenac epolamine
pharmaceutical raw material
Benzamide, 3-(5-((1R,2S)-2-((2,2-difluoro-1-oxopropyl)amino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((3R)-tetrahydro-3-furanyl)-
pharmaceutical raw material
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide;hydrochloride
XRVLHWIMNRBZNS-UHFFFAOYSA-N
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.Cl